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A B S T R A C T
Background: Psychiatric disorders are highly heterogeneous, deﬁned based on symptoms with little connection
to potential underlying biological mechanisms. A possible approach to dissect biological heterogeneity is to look
for biologically meaningful subtypes. A recent study Drysdale et al. (2017) showed promising results along this
line by simultaneously using resting state fMRI and clinical data and identiﬁed four distinct subtypes of de-
pression with diﬀerent clinical proﬁles and abnormal resting state fMRI connectivity. These subtypes were
predictive of treatment response to transcranial magnetic stimulation therapy.
Objective: Here, we attempted to replicate the procedure followed in the Drysdale et al. study and their ﬁndings
in a diﬀerent clinical population and a more heterogeneous sample of 187 participants with depression and
anxiety. We aimed to answer the following questions: 1) Using the same procedure, can we ﬁnd a statistically
signiﬁcant and reliable relationship between brain connectivity and clinical symptoms? 2) Is the observed re-
lationship similar to the one found in the original study? 3) Can we identify distinct and reliable subtypes? 4) Do
they have similar clinical proﬁles as the subtypes identiﬁed in the original study?
Methods: We followed the original procedure as closely as possible, including a canonical correlation analysis to
ﬁnd a low dimensional representation of clinically relevant resting state fMRI features, followed by hierarchical
clustering to identify subtypes. We extended the original procedure using additional statistical tests, to test the
statistical signiﬁcance of the relationship between resting state fMRI and clinical data, and the existence of
distinct subtypes. Furthermore, we examined the stability of the whole procedure using resampling.
Results and conclusion: As in the original study, we found extremely high canonical correlations between func-
tional connectivity and clinical symptoms, and an optimal three-cluster solution. However, neither canonical
correlations nor clusters were statistically signiﬁcant. On the basis of our extensive evaluations of the analysis
methodology used and within the limits of comparison of our sample relative to the sample used in Drysdale
et al., we argue that the evidence for the existence of the distinct resting state connectivity-based subtypes of
depression should be interpreted with caution.
1. Introduction
Psychiatric disorders are highly heterogeneous in terms of symptom
presentation and underlying biological mechanisms and are diagnosed
exclusively in terms of symptoms, which may not correspond to bio-
logical causes (Kapur et al., 2012) This, together with frequent
comorbidities between disorders, complicates clinical diagnosis and
hinders eﬀorts to understand biological mechanisms of disorders and to
develop better treatments. This problem has been known for a long
time, but little progress has been made and clinical decision-making is
still mostly done on the basis of symptoms. Recent initiatives such as
the Research Domain Criteria (RDoC) (Insel, 2014) aim to address this
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issue of heterogeneity by going beyond current diagnostic categories
and focusing analysis on diﬀerent domains of functioning and pa-
thology across multiple levels of analysis, including clinical symptoms,
behavior, and biology.
Many studies have used data-driven clustering methods in order to
ﬁnd new subgroups of clinical populations, based on either clinical or
biological data, with some degree of success (Marquand et al., 2016;
Chekroud et al., 2017). The dominant approach of clustering based on
clinical symptoms alone can provide new insights into psycho-
pathology, however, it may not yield subtypes that reﬂect underlying
biological diﬀerences. On the other hand, the variability of biological
data is more often than not unrelated to any speciﬁc psychiatric dis-
order or symptom class. Thus, clustering based on biological data alone
may detect subtypes that are unrelated to psychiatric pathologies, and
instead reﬂect dominant nuisance variance in the data such as groups of
people with similar brain size or body type or common ancestry in the
case of genetics. One way to overcome these limitations is to constrain
the search for subtypes in biological data to lie along axes of variance
that are related to psychiatric symptomatology. However, few studies
have used such an approach (Marquand et al., 2016).
A prominent example following this approach is a recent study by
Drysdale an colleagues (Drysdale et al., 2017) that aimed to stratify
major depressive disorder (MDD) on the basis of biology and behavior
and suggested the existence of four distinct biotypes. The authors used
canonical correlation analysis (CCA)(Hotelling, 1936) to identify a two-
dimensional mapping between functional connectivity measures de-
rived from resting state fMRI (RS-fMRI) data and MDD symptoms. CCA
is a well-established method for ﬁnding multivariate associations be-
tween diﬀerent data sources and has been used extensively in clinical
neuroimaging, for example for ﬁnding associations between neuroi-
maging data and behavior (Marquand et al., 2017; Smith et al., 2015)
and neuroimaging and genetics (Le Floch et al., 2012). Next, Drysdale
et al. applied a hierarchical clustering on two components derived from
CCA and identiﬁed four diﬀerent clusters of MDD patients, i.e. the
aforementioned biotypes. Impressively, these biotypes were predictive
of transcranial magnetic stimulation (TMS) treatment response, and
they were also evaluated in an independent sample. However, the study
has some methodological limitations. For example, the existence of
distinct clusters was not conclusively established in that the authors did
not test the possibility that subjects were sampled from a single con-
tinuous distribution without underlying clusters. Nevertheless, the re-
sults are promising, and if replicated it would be an important step
towards understanding biological mechanisms of MDD.
The aim of this study is to apply the analysis methods used by
Drysdale et al. to a completely independent sample from a diﬀerent
clinical population of patients with depression and anxiety disorders,
namely data from the Netherlands Study of Depression and Anxiety
(NESDA) (Penninx et al., 2008) and Mood Treatment with Anti-
depressants or Running (MOTAR) study (Lever-van Milligen et al., in
preparation). These studies together create a relatively large cohort
containing a heterogeneous sample of subjects with depression, anxiety
and comorbid depression and anxiety, thus capturing a wider range of
possible clinical and biological proﬁles relative to the study by Drysdale
and colleagues, which included mainly hospitalized treatment-resistant
patients in a currently active depressive episode. The original study
used 220 patients as a cluster discovery dataset and an additional 92
patients from the same cohort as a replication dataset. Our combined
dataset of NESDA and MOTAR includes a cohort of 187 participants
with clinical measures measured by a comparable clinical instrument.
Speciﬁcally, using the same procedure as in (Drysdale et al., 2017) but
in a diﬀerent clinical population, we aimed to answer the following
questions: 1) can we ﬁnd a statistically signiﬁcant and reliable re-
lationship between brain connectivity and clinical symptoms? 2) Is the
identiﬁed relationship similar to the one found in the original study? 3)
Can we identify distinct and reliable subtypes? 4) If so, do they have
similar clinical proﬁles as the subtypes identiﬁed in the original study?
We consider that the type of methodological replication we have
performed, that is, in a diﬀerent depressed population and with dif-
ferent measures of depressive symptoms provides a strong test of the
subtypes found in Drysdale et al. (2017) in that if our ﬁndings were
supportive, this replication would provide strong evidence for external
validity of the original ﬁndings. However, if they do not support the
original ﬁndings it could be diﬃcult to determine whether that is due to
the unreliability of the original ﬁndings or diﬀerences in the replication
sample. In addition and in view of the methodological considerations
described above, we will perform a critical evaluation of methods used
by Drysdale et al. and provide a recommendation for future studies. We
will argue that in the original study, whilst there is evidence for the
relationship between resting state connectivity and clinical symptoms,
the presented evidence does not conclusively support the existence of
biotypes of depression as proposed in the original study.
2. Methods
We conducted our analysis as closely to possible and to our best
understanding of the published analysis pipeline in the Drysdale et al.
study. Several details related to the analysis were not speciﬁed in the
original paper and were clariﬁed via personal communication with the
corresponding author. We included several additional validation steps
for CCA and cluster analysis. Our aim was to replicate the analysis steps
related to the creation and evaluation of subtypes, we did not try to
replicate additional analyses performed in the original study such as
classiﬁcation of healthy and depressed subjects or the prediction of TMS
treatment response. We describe our pipeline and the Drysdale et al.
pipeline below and provide a side by side schematic comparison in
Fig. 1.
2.1. Sample characteristics
All our analyses were performed on 187 subjects from NESDA and
MOTAR samples diagnosed according to DSM-IV criteria with MDD, an
anxiety disorder (i.e. panic disorder, social phobia or generalized an-
xiety disorder) or both MDD and an anxiety disorder, established using
the structured Composite International Diagnostic Interview (CIDI,
version 2.1) (Robins et al., 1988) at the time of intake. At the time of
scanning, subjects were additionally evaluated using the Inventory of
Depressive Symptomatology (IDS) (Rush et al., 1986) and the Beck
Anxiety Inventory (BAI). See Table 2 (Beck et al., 1988). At the time of
scanning, 18% of subjects were in remission for both IDS and BAI using
common clinical cutoﬀs. Considering IDS cutoﬀs alone, 30% of subjects
were not actively depressed at the time of scanning and an additional
34% of subjects had only mild severity.
The original Drysdale et al. study included 220 subjects in a cluster
discovery set and an additional 92 subjects in a validation set with an
active episode of MDD and a history of treatment resistance. In our
sample, 151 subjects came from the baseline assessment of NESDA
(Penninx et al., 2008), which is large naturalistic cohort study of de-
pression and anxiety (here, we have included the complete NESDA fMRI
substudy). Additional descriptions of the NESDA cohort can be found in
(van Tol et al., 2011). Clinical characteristics stratiﬁed by study site are
in Table 2. An additional 36 subjects were from the baseline assessment
of the MOTAR study (Lever-van Milligen et al., in preparation), which is
a randomized controlled treatment study (antidepressants or running
therapy).
Inclusion criteria for MOTAR and NESDA patient samples included
current major depressive disorder or current anxiety disorder (social
phobia, generalized anxiety disorder or panic disorder). Exclusion cri-
teria included use of antidepressants or other psychotropic medication
except benzodiazepine, presence of other psychiatric disorder except
depressive or anxiety disorder (bipolar disorder, psychosis, addictive
disorder), presence of acute suicidal risk, major neurological or internal
disorder, pregnancy or other known contra-indications for MRI such as
R. Dinga, et al. NeuroImage: Clinical 22 (2019) 101796
2
presence of metal objects or claustrophobia. MOTAR had additional
exclusion criteria: participation in regular exercise (at least once a
week) and medical contra-indications to running therapy or anti-
depressant use conﬁrmed by a physician.
In addition to the main analyses we report below, we also repeated
the analyses excluding patients with a ‘pure’ anxiety diagnosis, since
these were not included in the cluster discovery sample of the original
Drysdale study. These analyses are reported in the supplementary ma-
terial and led to similar conclusions.
All participants gave written informed consent. Studies were ap-
proved by the Central Ethics Committees of the participating medical
centers: Leiden University Medical Center (LUMC), Amsterdam Medical
Center (AMC), and University Medical Center Groningen (UMCG) for
NESDA and Ethics committee of Amsterdam Medical Center (AMC) for
MOTAR.
2.2. Resting-state fMRI
Participants from NESDA were scanned at one of the three partici-
pating scan centers and at one scan center for the MOTAR study. All
imaging data were acquired on a Philips 3.0-T Achieva MRI scanner. A
sense-8 (UMCG and LUMC) and a sense-6 (AMC) channel head coil was
used for radio frequency transmission and reception for the NESDA
study and Philips 3 T Achieva with 32 and 8 channel receive head coils
were used for the MOTAR study. RS-fMRI data were acquired using
T2*-weighted gradient-echo echo-planar imaging with the following
scan parameters for the NESDA sample: Amsterdam and Leiden centers:
200 whole-brain volumes; repetition time (TR)= 2300ms; echo time
(TE)= 30ms; ﬂip angle= 80°; 35 axial slices; no slice gap;
FOV=220×220mm; in plane voxel resolution=2.3mm×2.3mm;
slice thickness= 3mm; same in Groningen, except: TE=28ms; 39
axial slices; in plane voxel resolution= 3.45mm×3.45mm. And for
the MOTAR sample: 210 whole-brain volumes; repetition time
(TR)=2300ms; echo time (TE)= 28ms, ﬂip angle= 76.1°, 37 axial
slices, no slice gap; FOV=240×240, in plane voxel resolu-
tion= 3.3mm×3.3mm using interleaved slice acquisition order. T1-
weighted image was acquired with the repetition time (TR)= 9ms;
echo time (TE)= 3.5ms; ﬂip angle= 8°; 170 sagittal slices; no slice
gap; FOV=256×256mm; in plane voxel resolution=1mm×1mm;
slice thickness= 1mm.
Preprocessing steps in the original study were performed using
Analysis of Functional Neuroimages (AFNI) software package, using
motion scrubbing and ANATICOR to deal with artifacts. Here we have
performed preprocessing using FSL 5.0.8. Steps included motion cor-
rection using McFLIRT(Jenkinson et al., 2002) using default parameters
and registering each volume to the middle time point, grand mean
scaling of the fMRI time series, spatial smoothing with 6mm Gaussian
kernel, motion artifacts removal using ICA-AROMA (Pruim et al.,
2014). Additional nuisance signal regression compliant with the pipe-
line recommended in (Pruim et al., 2014) was performed by regressing
out mean signals from cerebrospinal ﬂuid (CSF) and white matter ex-
tracted using participant-level masks obtained by multiplying partici-
pant-level CSF and white matter segmentations obtained by automated
segmentation using FSL's FAST (Zhang et al., 2001) with the MNI152-
based CSF and white matter masks provided as part of FSL and thre-
sholded with a 0.95 threshold. The data were then high pass ﬁltered
with a cut-oﬀ frequency of 0.01 Hz. As in the original study, no slice
timing correction was performed. The resulting RS-fMRI images were
registered to Montreal Neurological Institute (MNI) space using trans-
formation matrices obtained from the ﬁrst co-registration of functional
images to T1 image using the boundary based registration tool and
registering the T1 images to MNI template brain using FMRIB's linear
image registration tool (FLIRT) (Jenkinson et al., 2002). Following
preprocessing, we performed carefully assessed data quality in align-
ment with the checks performed in the original study. These are re-
ported in the supplementary material and show that the level of head
Fig. 1. A scheme of the pipeline used in the original study and our pipeline. Data: in the original study, 220 depressed subjects have been analyzed as a part of a
“cluster discovery” set and an additional 92 subjects were used as evaluation set. The clinical data (Clin) consisted of 17 HAM-D items. We have used 187 subjects
with depression, anxiety disorder or depression-anxiety comorbidity. The clinical data consisted of 17 IDS items that best-matched the HAM-D item used in the
original study. After preprocessing of fMRI data (RS), a correlation matrix between selected regions was created, resulting in ~35,000 features. A small subset of
features (178 in the original study and 150 in our study) were selected based on their correlation with clinical symptoms (Sel.RS). Then, CCA was performed using
these selected features and clinical symptoms. In the original study, a parametric test was used to the established statistical signiﬁcance of CCA without taking a
previous feature selection into an account. Hierarchical clustering was performed on ﬁrst two resting state connectivity canonical variates (CV1, CV2). We have
included an additional test, to test if the data cluster more than what is expected from data sampled from a Gaussian distribution. Stability of cluster assignment was
evaluated in the original study by resampling of CV1 and CV2, We have extended the resampling stability evaluation to feature selection (in addition to the CCA
procedures). Out of sample evaluation: in the original study, an additional 92 subjects were assigned to clusters according to a SVM model and clinical proﬁles of
these clusters were compared to clinical proﬁles of clusters obtained in the cluster discovery set. We have evaluated the reproducibility of canonical correlations
directly, using 10-fold cross-validation.
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motion in our cohort was similar to that in the Drysdale study. Note that
there are some diﬀerences between the pipeline we employed here and
that was used in the Drysdale study. Most notably, we employed ICA-
AROMA in place of volume censoring. There is good evidence that ICA-
AROMA does at least as well as volume censoring in removing motion
artifacts, whilst preserving greater temporal degrees of freedom in the
fMRI time series (Pruim et al., 2014; Parkes et al., 2018). We show that
ICA-AROMA performed well in removing head motion-related artifacts
in our data (Supplementary ﬁg. 4).
Next, correlation matrices were created using 264 cortical parcel-
lations proposed by Power et al. (2011) plus an additional 13 regions,
including the left and right caudate, amygdala, hippocampus, nucleus
accumbens and subgenual anterior cingulate cortex, as in the original
Drysdale et al. study. We averaged all voxels within each region to
create a single time series per region. We have discarded 1% of regions
with the lowest signal to noise ratio, and subsequently created a cor-
relation matrix by computing pairwise Pearson's correlation coeﬃcients
between all regions. This resulted in 38,000 connectivity features
(lower diagonal of 277*277 correlation matrix), which were later re-
duced to 37,675 by discarding regions with insuﬃcient coverage
in>10% of subjects. These correlations were transformed using Fish-
er's z-transform and linear eﬀects of age, frame-wise displacement and
dummy coded study site were regressed out.
2.3. Clinical characteristics
The original study used depressive symptom scores of the Hamilton
rating scale for depression (HAMD) (Hamilton, 1960) in their analyses.
Here we used depressive symptom scores derived from the self-rated
Inventory of Depressive Symptomatology (IDS) (Rush et al., 1986). This
inventory was developed as an improvement over HAMD, aiming to
improve the coverage of common MDD symptoms (Rush et al., 1996).
However, to make our study comparable to the original study, we used
only a subset of 17 IDS items that best matched the items of the HAMD
(Table 1).
2.4. Feature selection
From the 37,675 connectivity features (the lower diagonal of the
functional correlation matrix), we selected the subset of features with
the highest Spearman's correlation with any of the 17 IDS symptoms. In
the original study, according to communication with the corresponding
author, during feature selection, the number of RS-fMRI features cor-
responding to approximately 80% of the total number of participants
were retained, which corresponds to 176 RS-fMRI connectivity features
in a sample of 220 participants in the original study. Here we selected
the top 150 RS-fMRI features with the highest Spearman's correlation
with any of the 17 IDS symptoms to preserve the same feature to sub-
jects ratio (80% of 187 subjects).
2.5. Canonical correlation analysis
Next, following the original study, we performed a canonical cor-
relation analysis (CCA) on the selected RS-fMRI connectivity features
and depressive symptoms. Canonical correlation analysis (Hotelling,
1936) is a multivariate statistical method that seeks an association
between two sets of variables. CCA is the most general multivariate
technique with multiple regression, MANOVA, and discriminant ana-
lysis all as special cases of CCA (multiple regression is a CCA with only
one variable in Y, MANOVA, and discriminant analysis are CCA with
binary variables in X or Y). Given the two multidimensional datasets X
(e.g. clinical features) and Y (e.g. RS-fMRI connectivity features), ca-
nonical correlation analysis ﬁnds a linear combination of X that maxi-
mally correlates with a linear combination of Y. This linear combina-
tions of X and Y are new variables, called canonical variates. Both
canonical variates for X and Y are called a canonical pair and the cor-
relation between canonical variates is called a canonical correlation.
Multiple canonical pairs can be found with a constraint that each
subsequent canonical pair has to be uncorrelated with all the previous
ones.
CCA is also closely related to PCA with a diﬀerence that CCA per-
forms eigen decomposition of the cross-correlation matrix instead of the
correlation matrix. In PCA the ﬁrst principal component explains the
largest amount of variance in the data, and each subsequent principal
component explains a (smaller) maximal amount of variance that is
orthogonal to all the previous ones. In CCA the ﬁrst canonical variate of
X explains the largest amount of variance in Y and each subsequent
canonical variate is explaining less of variance in Y and is orthogonal to
all the previous canonical variates. In more detail, the squared cano-
nical correlations are eigenvalues of the matrix:
=
− −R R R R Ryy 1 yx xx 1 xy
where Rxx and Ryy are correlation matrices of X and Y, respectively, and
Rxy and Ryx are cross-correlation matrices of variables from X with
variables from Y. Coeﬃcients that create the canonical variates are the
respective eigenvectors of R. CCA can be also thought of as a di-
mensionality reduction step, where the original data of X and Y are
mapped into a lower dimensional space of canonical variates whose
dimensions are highly correlated between datasets X and Y, in our case
between RS-fMRI connectivity measures and clinical symptoms.
2.5.1. Permutation test
Traditionally, the signiﬁcance of canonical correlations is estab-
lished using a Wilk's lambda statistic and this was also used in the
Drysdale study (Conor Liston, personal communication). This statistic
has an approximately chi-square null distribution with pq degrees of
freedom, p and q being the number of variables in X and Y. This sig-
niﬁcance test, however, does not take into account the feature pre-se-
lection step that selected RS-fMRI connectivity features most correlated
with clinical symptoms. As this pre-selection step was done in the same
dataset as the CCA was performed on and tested, this likely results in
too optimistic p-values. To avoid overly optimistic p-values, we per-
formed a permutation test of the whole procedure, i.e. feature selection
followed by CCA. The whole feature selection and CCA cycle was re-
peated for each permutation with the rows of clinical symptoms shuf-
ﬂed so that they no longer corresponded to rows of RS-fMRI con-
nectivity features. We performed 1999 permutations, which created a
null distribution of canonical correlations and estimated the Wilk's
lambda statistic. The interpretation of Wilk's lambda statistic is also
important, because it does not describe the signiﬁcance of a single
Table 1
HAM-D items used in the original study and best-matched IDS items used in this
study.
HAMD item IDS item
Mood Feeling sad
Guilt Self criticism and blame
Suicide Thoughts of death or suicide
Early insomnia Early insomnia
Mid insomnia Mid insomnia
Late insomnia Late insomnia
Anhedonia Capacity for pleasure or enjoyment (excluding sex)
Retardation Psychomotor retardation
Agitation Psychomotor agitation
Anxiety psychological Feeling anxious or tense
Anxiety physiological Other bodily symptoms/sympathetic arousal
Somatic gastro-internal Gastrointestinal complaints
Fatigue/aches/low energy Energy level/fatiguability
Genital Interest in sex
Hypochondria Somatic complains
Weight loss Weight loss
Insight Sensitivity
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component in isolation. Instead, the ﬁrst canonical correlation is de-
ﬁned as det(E)/det(E+H), where E is the error sum of squares and
cross products matrix and H is model sum of squares and cross products
matrix. Its signiﬁcance should be interpreted as the signiﬁcance of the
whole decomposition, not the ﬁrst component. The signiﬁcance of the
Wilk's lambda statistic for the second canonical correlation is inter-
preted as the signiﬁcance of the whole decomposition after removing
the variance accounted for by the ﬁrst canonical correlation and so
forth. In addition, if the canonical correlation from a given model order
(e.g. ﬁrst canonical correlation) is not signiﬁcant, all correlations of a
lower order (e.g. second onwards) should not be taken to be signiﬁcant
either, even if one or more of the derived p-values show nominal sig-
niﬁcance (Sherry and Henson, 1981).
2.5.2. Cross-validation
CCA is prone to overﬁtting and although canonical correlations may
seem high and even be statistically signiﬁcant, they are often much
lower in an independent dataset (see e.g. (Le Floch et al., 2012)). This
might give an impression that the found association between modalities
(RS-fMRI connectivity measures and clinical symptoms) is much
stronger than it would be in an independent hold-out dataset. In the
original study, the canonical correlation in the independent data set
was not evaluated directly in an independent dataset, but rather the
authors relied on the derived biotypes to have similar symptom proﬁles
in the independent evaluation dataset.
Here we chose to estimate the magnitude of canonical correlation
out of the training sample, using stratiﬁed 10-fold cross-validation. The
dataset was divided into ten subsets with an approximately constant
number of subjects from each study site across all subsets. Nine subsets
were used as a training set and the remaining subset as a test set. A
feature selection procedure, as described above, was performed using
subjects from the training set only. In the test set, canonical variates and
their respective canonical correlations were created using coeﬃcients
from the CCA performed in the training set.
2.5.3. Stability of canonical loadings
Since CCA frequently yields unstable solutions, we also examined
the stability of canonical loadings (i.e. structure coeﬃcients, a uni-
variate correlation between a variable and canonical variate) (Sherry
and Henson, 1981) under resampling of the data. We have performed a
delete-one jack-knife procedure (similar to leave-one-out CV) (miller,
1974), which a statistical technique closely related to bootstrap used to
estimate sampling variability of statistics that would be otherwise hard
or impossible to compute analytically. We repeated the whole feature
selection and CCA procedure multiple times always with leaving one
subject out of the analysis. This produces a distribution of canonical
loadings and thus allows us to estimate their stability, and therefore
uncertainty, under small perturbations of the data (here by exchanging
one subject) taking into an account both the feature selection step and
the CCA step. Perturbation of data by leaving one subject should be tiny
compared to other resampling schemes, thus providing a very con-
servative estimate of the stability of the procedure. In other words, if
the solution is not stable after removing only one subject, it will not be
stable under more extensive resampling.
2.6. Clustering analysis
In the original study, the ﬁrst two canonical variates of the RS-fMRI
connectivity features were used as input for the clustering analysis. The
underlying idea was to constrain the clustering analysis to a low di-
mensional representation of brain connectivity features that are clini-
cally relevant. The authors used a hierarchical clustering procedure
using the Euclidean distance measure and Ward's D linkage method,
which minimize the total within-cluster variance. The original study
identiﬁed a solution with four clusters as the best clustering solution
partly because the CH index (variance ratio criterion or Calinski-
Harabasz index) was maximized for the four cluster solution.
We followed the same procedure but in addition to the CH index we
also computed the silhouette index, which compares average within
cluster distances to average distances between points from diﬀerent
clusters. We also performed an additional procedure to test whether the
observed CH and silhoutte indices are unlikely to occur under null
hypothesis of no clusters. Although the CH index was in the original
study maximized for four cluster solution, this, by itself, is not a sta-
tistical test or evidence of the existence of four clusters. Speciﬁcally, we
don't know if the derived CH index was signiﬁcantly higher than what
would have been expected under the null hypothesis of data with no
underlying clusters. Here we devise a procedure, similar to the one
proposed in Liu et al. (2008),to test the statistical signiﬁcance of the
observed CH index. In this procedure, the null hypothesis is that the
data came from a single 2-dimensional Gaussian distribution (i.e. dis-
tribution with no underlying clusters). Speciﬁcally, ﬁrst, we estimated a
covariance matrix between the two canonical variates used for the
clustering analysis. Second, we repeatedly took random samples of the
size of our dataset (187) from a bivariate Gaussian distribution deﬁned
by this covariance matrix. Third, we ran the same hierarchical clus-
tering procedure as we performed on the real data on each random
sample and calculated the best obtained CH and silhouette index, thus
obtaining an empirical null distribution of these indices. The p-value
was then deﬁned as a proportion of the calculated indices in the null
distribution smaller than what we observed in the real data.
To make our analysis comparable to the original study, we decided
to perform a clustering analysis on two diﬀerent sets of canonical
variates. First, as in the original study, we performed clustering analysis
on the ﬁrst two RS-fMRI connectivity canonical variates, which were
the two RS-fMRI components with the highest canonical correlations.
Second, because the ﬁrst two components in our analysis may not
correspond to the ﬁrst two components identiﬁed in the original study,
we visually selected two canonical variates that showed the most si-
milar clinical proﬁles to those identiﬁed in the original study.
2.6.1. Stability of clustering
To reliably interpret the derived clusters, it is important to evaluate
if the clustering assignment is stable under small perturbations to the
data. In other words, if the same procedure was repeated using a similar
dataset, would we identify similar clusters and would we assign the
same subjects to the same clusters? This is a diﬀerent question than if
the clusters are statistically signiﬁcant, because cluster assignment
might be stable even if there are no real clusters in the data. On the
other hand, it is possible to obtain clearly distinct clusters that are
unreliable and cannot be reproduced in a diﬀerent dataset. For this, we
employed the same leave-one-out procedure as for the estimation of the
stability of the canonical loadings. The whole feature selection, CCA,
and hierarchical clustering procedure were repeated for each subject,
always with one subject left out of the training process. This allowed us
to estimate the stability of the canonical variates under slight pertur-
bation of the data and subsequently the stability of the whole clustering
procedure that is based on these canonical variates. As noted above,
perturbation of removing one subject should be weak, and therefore
this provides a very conservative test of stability in the sense that if the
solution is not stable under a leave-one-out procedure it will not be
stable under a greater perturbation to the data.
2.7. Code availability
The code used to perform data analysis can be found in supple-
mentary materials and also at https://github.com/dinga92/niclin2019-
biotypes.
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3. Results
3.1. Sample characteristics
Sample characteristics are provided in Table 2.
3.2. CCA signiﬁcance
Canonical correlations were 0.99 and 0.97 for the ﬁrst two pairs of
canonical variates. As can be seen in the null distribution provided in
Fig. 2, canonical correlations this high are not unusual even if there is
no actual correspondence between X and Y (as determined by a per-
mutation test). Indeed, the respective p-values of the permutation tests
were not signiﬁcant (p=0.64 and p=0.99), neither were they sig-
niﬁcant according to the Wilk's lambda statistics (p= 0.99 and
p=0.99), which measured the signiﬁcance of the whole decomposi-
tion. Our permutation testing procedure took into account that con-
nectivity features had been selected based on their correlation with
clinical features. In contrast, p-values computed analytically using tra-
ditional chi-square approximation of the null distribution of the Wilk's
lambda statistics with pq degrees of freedom, p and q being the number
of variables in X and Y, were < 0.0001. Because the Drysdale et al.
study did not test the signiﬁcance of their CCA solution in the same
way, it remains to be conﬁrmed whether the canonical variates iden-
tiﬁed in their original study were signiﬁcant, although authors did
provide indirect evidence of this using an independent validation
sample.
3.2.1. Out of sample canonical correlation
Using 10-fold cross-validation, the average out of sample canonical
correlation across folds was 0.07 and −0.07 for the ﬁrst and second
canonical pair, respectively (see Section 2.5.2), in contrast to the
within-sample canonical correlation of 0.99 and 0.97. Canonical cor-
relations for each test fold can be seen in Fig. 2D. This shows that even a
high within-sample canonical correlation might not necessarily be re-
producible in an independent test set. The original study used an in-
dependent evaluation set of 92 subjects. However, the authors did not
perform a CCA analysis in the independent sample directly and thus did
not provide canonical correlations for the independent validation da-
taset. Instead, they demonstrated that subjects assigned to clusters in
the validation set according to their RS-fMRI connectivity features
showed similar clinical proﬁles as the clusters identiﬁed in the training
set.
3.2.2. CCA similarity of loadings
A side-by-side comparison of canonical loadings (univariate corre-
lation between each variable and the canonical variate) of all our re-
sulting canonical variates and the ﬁrst two canonical variates reported
in Drysdale et al. are provided in Fig. 2f. We also conducted an analysis
of stability of these loadings under small resampling of the data by
repeating the feature selection and CCA procedure 187 times, each time
without one subject left out of the analysis. The results for this analysis
can be seen in Fig. 2e. It can be seen that even by changing one subject
in the pipeline, individual loadings changed dramatically. Because of
this instability and the fact that our canonical variates were not sta-
tistically signiﬁcant, it was not found meaningful to compare our
loadings with loadings found in the original study.
3.3. Clustering signiﬁcance
In our dataset, a 3-cluster solution showed the highest CH (109) and
also the highest silhouette index (0.34) (Fig. 3C and D, respectively).
However, using a simulation approach described in the methods sec-
tion, these indices were not statistically signiﬁcant (p=0.45 and
p=0.19 for CH and silhouette index, respectively). That means that it
is not unusual to observe such high CH and silhouette indices, even
when the hierarchical clustering is performed on a normally distributed
data set (data with no clusters). Formally, this means that we cannot
reject the null hypothesis of the data coming from a single Gaussian
distribution (Fig. 3). In the original study, this was not tested. There-
fore, we cannot say if the data in the original study really formed
clusters, instead of just random ﬂuctuation of the data.
3.3.1. Cluster stability
We evaluated cluster assignment stability under slight resampling of
the data by performing the feature selection and CCA procedure again,
with one subject left out of the pipeline. The results are shown in the
Fig. 3a and b. The ﬁgures show the position of each subject with respect
to the ﬁrst two canonical variates and therefore how clusters changed
just by changing one subject in the pipeline. Stability of cluster as-
signment was performed in the original study by bootstrap procedure
after feature selection and CCA, thus not taking instability of these two
steps into account.
Table 2
Sample characteristics for the NESDA (stratiﬁed by study site) and MOTAR samples.
NESDA 1 NESDA 2 NESDA 3 MOTAR Total
N 32 57 62 36 187
Age (SD) 36 (9.52) 37.26 (10.26) 35.87 (11.51) 36.69 (12.37) 36.48 (10.93)
N Female (%) 19 (59%) 39 (68%) 43 (69%) 23 (66%) 124 (66%)
N MDD (%) (no anx. disorder) 13 (40%) 18 (32%) 22 (35%) 10 (28%) 63 (34%)
N Anxiety disorder (%) (no MDD) 11 (34%) 13 (22%) 21 (34%) 2 (6%) 47 (25%)
N Comorbid (%) 8 (25%) 26 (45%) 19 (30%) 24 (67%) 77 (41%)
Current⁎ IDS (SD) 22.31 (9.66) 24.66 (11.45) 19.93 (12.42) 15.81 (10.56) 21.11 (11.96)
Current⁎ IDS categorical none/mild/moderate/severe/very severe 5/16/9/1/1 10/18/22/6/1 22/20/16/2/2 19/10/5/2/0 56/64/52/11/4
Current⁎ BAI (SD) 13.19 (8.45) 13.33 (9.73) 13.34 (9.35) 21.67 (11.95) 14.91 (10.34)
Current⁎ BAI categorical none/mild/moderate/severe 11/3/7/1 22/19/13/3 27/18/12/5 5/11/11/9 65/61/43/18
N in remission (IDS and BAI) 3 (9%) 10 (18%) 16 (25%) 5 (14%) 34 (18%)
Baseline antidepressant use 7 (21%) 20 (35%) 23 (37%) 0 (0%) 50 (26%)
Social phobia 12 (37%) 23 (40%) 23 (37%) 15 (42%) 73 (39%)
Panic with agoraphobia 6 (18%) 13 (22%) 17 (27%) 8 (22%) 44 (24%)
Panic without agoraphobia 4 (13%) 11 (19%) 9 (15%) 1 (3%) 25 (13%)
Agoraphobia 4 (13%) 3 (5%) 3 (5%) 0 (0%) 10 (5%)
GAD 7 (22%) 16 (28%) 15 (24%) 7 (19%) 45 (24%)
Anxiety disorder: one or more of panic disorder, generalized anxiety disorder, social phobia, and agoraphobia. IDS: inventory of depressive symptomatology. BAI:
Beck anxiety inventory. GAD: generalized anxiety disorder. IDS categorical cutoﬀs: 0–13/14–25/26–38/39–48/49–84. BAI categorical cutoﬀs (Kabacoﬀ et al., 1997):
0–9/10–18/19–29/30–63.
⁎ At the time of scanning.
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3.3.2. Clustering similarity
Since we did not ﬁnd evidence for clusters in our data, and the
cluster assignment was not stable, we did not consider it meaningful to
describe clusters in terms of their symptom proﬁles or compare the
clusters in our study to clusters identiﬁed in the original study.
4. Discussion
Here, we aimed to replicate the analytical pipeline proposed by
Drysdale and colleagues (Drysdale et al., 2017) and extend their
ﬁndings to a diﬀerent clinical population. More speciﬁcally, we applied
their stratiﬁcation approach to a similarly sized dataset of a hetero-
geneous sample of patients with depression and anxiety disorders, i.e.
with diﬀerent clinical characteristics to the original sample (which in-
cluded only subjects with currently active treatment-resistant depres-
sion) and with clinical symptoms measured with a diﬀerent but com-
parable instrument. We followed the analysis steps of the original study
as closely as possible and obtained extremely high canonical correla-
tions (0.99 and 0.97) and optimal 3 cluster solution. However, after
performing additional tests that were not performed in the original
Fig. 2. A, B) CCA ﬁnds a linear combination (canonical variate) of brain connectivity features that maximizes correlation with a linear combination of clinical
symptoms. Canonical correlations are high and comparable to the original study (0.95 and 0.91). C) The null distribution of the ﬁrst canonical correlation obtained
using permutation test. Although canonical correlations in A and B are seemingly high, they are also high under the null hypothesis and thus not statistically
signiﬁcant. D) Out of sample canonical correlation for ﬁrst two canonical pairs estimated by 10 fold cross-validation. Each point represents out of sample canonical
correlation for each cross-validation fold. Although the canonical correlation was high in the training set as showed in A and B, id dropped to a chance level
correlation in the test sets. E) Canonical loadings for the ﬁrst canonical variate and their stability under resampling of the data using leave-one-out (jack-knife)
procedure. F) Clinical canonical loadings for all canonical variates (1–17) and ﬁrst two reported in the original study (D1-D2).
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study, which took into account that the RS-fMRI connectivity features
were selected based on their correlation with clinical features before
performing CCA on these connectivity and clinical features, even the
high canonical correlations that we observed were not statistically
signiﬁcant and they did not replicate outside of the training set. By
using the same criteria for selecting the number of clusters as in the
original study, we found an optimal three cluster solution. However, we
showed that this cluster solution would happen even if the data came
only from a single Gaussian distribution with no underlying clusters.
4.1. Statistical signiﬁcance of canonical correlations
The ﬁrst two canonical correlations between brain connectivity and
clinical symptom measures that we observed in our data were high
(0.99 and 0.98). However, they were not statistically signiﬁcant as
determined by permutation testing. In addition, using cross-validation,
the canonical correlations dropped to approximately 0 in the test set.
This is not unexpected because of the high number of variables included
compared to the number of subjects in this sample, which leads to
severe overﬁtting. CCA is known to be unstable; for example, in-
troductory texts recommend between 10 and 42 subjects per variable in
order to obtain a reliable CCA model (Tabachnick and Fidell, 2001;
Pituch et al., 2016), but the pipeline used in the original study that we
followed had around 1.3 subjects per variable. Another important
contribution for the overly optimistic canonical correlations is the in-
itial feature selection step that selected 150 connectivity features in our
study (178 in the original study) out of ~30,000 brain connectivity
measures that were most correlated with the clinical symptoms in the
same dataset in which the CCA was performed.
In the original study by Drysdale and colleagues, this feature se-
lection step was not taken into account when estimating the statistical
signiﬁcance of the canonical correlations, thus the reported p-values
were likely inﬂated. Moreover, the replication of canonical correlations
out of sample was not shown directly in the study by Drysdale and
colleagues. Despite this, the authors did provide indirect evidence for a
reliable relationship between brain connectivity measures and clinical
symptoms in a subset of subjects left out completely from the primary
analysis (training set). These subjects were assigned to clusters based on
Fig. 3. A) obtained 4-cluster solution using
hierarchical clustering. B) Stability of the
cluster assignment. Each subject is shown
with the same color as it had in A, but the
connectivity scores are recomputed under a
small perturbation of the data i.e. leaving
one subject out of the feature selection and
CCA procedure. C) Variance ratio criterion
is maximized at 3 clusters (4 in the original
study). D) Silhouette index is maximized at
3 clusters. E, F) Null distribution of
Variance ratio and silhouette indices.
Showing that although these indices are
maximized at 3 clusters, these results are
not unusual even for the data simulated
from a distribution with no clusters.
Therefore these criteria do not imply evi-
dence for the existence of clusters in our
data or in the data presented in the original
study.
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a support vector machine classiﬁer using only their connectivity fea-
tures as predictors, and these clusters had similar clinical symptom
proﬁles in their cluster discovery and replication sets, which would not
be possible if there is no real relationship between biological and
clinical variables. However, in view of the methodological considera-
tions above, this does necessarily mean that the relationship is exactly
in the form of anxiety and anhedonia-related components as reported in
the original study.
4.2. Similarity of canonical loadings
Due to the overﬁtting of CCA discussed above, the canonical load-
ings we obtained were unstable, which makes their comparison with
loadings reported in the original study diﬃcult. Despite that, loadings
of our fourth canonical variate were most similar to the loadings of the
second canonical variate reported in the original study by Drysdale and
colleagues. However, our canonical variates were not statistically sig-
niﬁcant.
4.3. Clustering analysis
A problem with many clustering algorithms that is not commonly
recognized is that they always yield clusters, regardless of the structure
of the data, even if there are no clusters at all (Liu et al., 2008). Many
procedures employed to determine the optimal number of clusters, in-
cluding the one used in the original study, are therefore more heuristic
and do not provide a statistical test of the underlying structure of the
data. In the original study, a four-cluster solution was decided to be
optimal mainly because the CH criterion, a speciﬁc numerical value
describing how well the data form clusters, was maximized by four
clusters. According to this criterion, we would have chosen an optimal
number of clusters to be three (or two according to the silhouette cri-
terion) in our data. However, after a closer examination, we observed
that a CH index as high or higher as we observed, can be easily obtained
just by running the same hierarchical clustering procedure on data
randomly sampled from a distribution that does not contain any clus-
ters (in this case Gaussian distribution). Or in other words, according to
the CH index, we could not reject the null hypothesis that our data
came from a single Gaussian distribution. No test for the existence of
clusters was performed in the original study and the presented data in
Fig. 1 of the original study looked more like a continuous distribution
instead of 4 clusters. On the basis of these methodological considera-
tions, we think that the original study provided insuﬃcient evidence to
conclude that any number of distinct biotypes of depression was more
likely than no biotypes at all.
Although the absence of clusters would change the conclusion of the
original study, it is not necessarily detrimental to the signiﬁcance of the
results. The found biological axes related to diﬀerent depressive
symptoms are important in their own merit, without subsequent arbi-
trary dichotomization into four biotypes. Two canonical variates al-
ready provide a parsimonious representation of the data and dividing
them further into four subtypes would not provide any more insights
into mechanisms of depression (especially if these subtypes are spur-
ious).
Assuming biotypes is also detrimental for the sake of clinical utility,
such as predicting the probability of a TMS treatment response. Since
the subtypes were predictive of TMS treatment response and were based
on the underlying canonical variates, it is reasonable to assume that the
probability of response varies smoothly with respect to the canonical
variates. Using only discrete subtypes for prediction assumes that all the
subjects in one “biotype” have the same chance for response. Also, very
similar subjects might get signiﬁcantly diﬀerent predictions. If a subject
would move slightly from biotype 1 to bordering biotype 2, his pre-
dicted TMS response chance would jump from 80% to 20%. Even if the
biotypes were truly distinct, but the probability of a response would
vary smoothly with respect to canonical variates, instead of discretely
with respect to subtypes, the model using continuous variables as pre-
dictors will perform better than a model using only subtype informa-
tion.
On the other hand, using subject-speciﬁc connectivity scores alone,
without additional arbitrary dichotomization into biotypes, would
allow making an individualized prediction for each individual, in line
with goals of personalized precision medicine. A clinical decision can
then be made for each patient individually according to their treatment
response probability instead of the average treatment response prob-
ability of the whole group (e.g. biotype). Critically, the availability of
quantitative measures means that cut-oﬀ points for various levels of
severity can be changed and ﬁne-tuned as more data from future studies
become available— as has been done for diseases such as hypertension.
Severity cut-points explicitly acknowledge dimensions and move away
from traditional single disorder models. Such a dimensional approach,
which captures the full spectrum of brain connectivity alterations,
provides an empirical and coherent framework to accommodate co-
morbidity and sub-threshold symptoms.
Due to the clinical heterogeneity of many psychiatric disorders and
the quest for personalized medicine, there is a tendency towards sub-
typing and expanding psychiatric nosology. However, the presumption
of distinct and homogeneous subtypes might not be clinically useful and
might not represent the underlying biology. Many clustering ap-
proaches will always produce some clusters and would so even for
uniformly distributed data. It is, therefore, crucial to distinguish real
biologically or clinically meaningful subtypes from random ﬂuctuation
of the data. This is not an easy task, however, several methods exist.
One possibility is to use simulations to create an empirical null dis-
tribution of clustering statistics, similar to what we used here as pro-
posed by (Liu et al., 2008) or use model-based approaches, such as
latent class analysis or Gaussian mixture models, where the model ﬁt
can be tested directly.
4.4. Recommendations for future studies
We have several recommendations for future studies. First, to avoid
overﬁtting and unstable results of CCA, we advise to either reduce the
number of features to limit the feature to sample ratio which can be
done by using a dimensionality reduction method, such as PCA, ICA or
factor analysis as used in Smith et al. (2015), or to use a regularized
version of CCA, or both as used in Le Floch et al. (2012). Second, if a
feature selection step is involved, it is necessary to take this into ac-
count in the statistical testing procedure, either by doing a statistical
test in an independent test set or by incorporating this selection step
into a permutation testing procedure (Kriegeskorte et al., 2009). For
clustering analysis, it is necessary ﬁrst to answer the question if there
are actually real clusters in the data or just random ﬂuctuations. Clus-
tering coeﬃcients and cluster assignment stability evaluation do not
test for this. To estimate cluster stability assignment it is important to
take the whole procedure into account, including feature selection and
CCA, which might show that even seemingly stable clusters are un-
stable. Finally, if the goal is a clinically useful prediction and high ac-
curacy, continuous variables should be preferred before dichotomizing
data into clusters because they contain more information and thus lead
to better prediction.
4.5. Limitations
There are several potential limitations mostly arising from our study
not exactly matching the original study, thus this study cannot be
considered a direct replication. Non-exact replications like the current
study provide a high level of evidence for the robustness and external
validity of the original ﬁnding if they are replicated because they show
that the original results do not depend on speciﬁc study design choices
and that they can be generalized to diﬀerent populations(Rosenthal,
1990) On the other hand, if they fail to support the original ﬁndings, it
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is hard to diﬀerentiate whether this failure is due to diﬀerences be-
tween studies or because the original ﬁnding was a false positive. Our
study diﬀered from the original in some preprocessing steps, the clinical
instrument used to assess depressive symptoms and clinical character-
istics of the sample.Our preprocessing pipeline diﬀered in several ways,
the most notable was our choice to handle motion-related artifacts
using ICA-AROMA instead of motion scrubbing. It has been shown re-
peatedly that AROMA performs at least as well as motion scrubbing in
reducing motion-related artifacts (Pruim et al., 2014; Parkes et al.,
2018), with the additional beneﬁt of keeping the number of available
timepoints constant across subjects. It is possible that diﬀerent pre-
processing choices would yield diﬀerent results, however, biological
eﬀects should not disappear by changing to an analogous preprocessing
pipeline. An additional diﬀerence is that our data were obtained from
four scan-sites with diﬀerent average symptom severity, compared to
two scan -sites with similar average symptom severity in the original
study. This limits the statistical power of our analysis because cor-
recting for site eﬀects will remove all depression-related connectivity
eﬀects in the data that can be explained by site eﬀects. Especially
subjects from the MOTAR study have on average one standard devia-
tion lower depression severity symptoms than the rest of the subjects
from the remaining 3 study sites. However, this does not aﬀect our main
conclusions about the tendency of the procedure used in the original
study to produce overly optimistic results.In the present study, the as-
sessment of clinical symptoms was performed using the self-report IDS
instrument compared to a clinician-administered (HAM-D) used the
original study. Both instruments are widely used and represent gold-
standard rating scales for depression in clinical research (Cusin et al.,
2009). Responses to the two diﬀerent instruments are highly correlated,
and their speciﬁc items are related to mostly overlapping symptoms
(Rush et al., 1996; Gullion and Rush, 1998). In general, replication of
eﬀects using diﬀerent instruments provides evidence that the found
association is characteristic of the pathology rather than the speciﬁc
instrument. Speciﬁcally, the original study found an association with
biology and anxiety, which should not depend on the precise way in
which speciﬁc anxiety-related items were worded. That being said,
diﬀerent items, although measuring mostly the same symptoms, are
likely to have a diﬀerent correlation structure, which in turn might
produce diﬀerent loadings in CCA. Indeed we did not ﬁnd the exact
same loadings as in the original study, however, we have also shown
that the CCA procedure was unstable due to overﬁtting. Therefore, a
direct comparison between loadings observed in our study and the
original study is was found not meaningful regardless of the instrument
being used.Our sample characteristics were diﬀerent from the original
study, which included only subjects with a currently active episode of a
treatment-resistant major depressive disorder. In contrast, we included
subjects with a wider range of diagnoses, including MDD and anxiety
disorders and a wider range of symptom severity from sub-threshold
depression (i.e. MDD subjects in remission at the time of scanning) to
people with an active MDD episode with mild, moderate and severe
symptoms. Our sample was recruited from the general population,
primary care and specialized mental health care. We believe that the
inclusion of pure anxiety disorder patients is especially appropriate
because the original study identiﬁed an anxiety associated CCA com-
ponent and an anxiety-associated biotype. Moreover, the authors of the
Drysdale study also applied their model to patients with generalized
anxiety disorder and concluded that connectivity abnormalities over-
lapped signiﬁcantly with those in patients with depression. For the
generalizability of the original ﬁndings, it is important to show that any
found association exists also in a population in a naturalistic setting
where the depressive phenotype is simultaneously less severe, more
heterogeneous and more reﬂective of the variability in the MDD phe-
notype in the general population. Studies showed a diﬀerence in resting
state activity between remitted and actively depressed subjects (Cheng
et al., 2019; Dong et al., n.d.). A wider range of symptoms could, on one
hand, translate to more diverse biology and thus make the connection
between clinical symptoms to biology more apparent. On the other
hand, higher heterogeneity might have the opposite eﬀect if the un-
derlying biological mechanisms diﬀer. Speciﬁcally, the power of our
study to ﬁnd signiﬁcant eﬀects would be decreased if speciﬁc symptoms
have diﬀerent eﬀects on functional connectivity in diﬀerent groups of
patients (i.e., active and non-active depressive disorder or depressive
disorder and anxiety disorder). However, our main conclusions of po-
tential unreliability of the original ﬁndings are not based on observing a
diﬀerent eﬀect as in Drysdale et al., but are based on performing ad-
ditional suﬃciently rigorous statistical tests, thus showing that the
analytical methods used in the original study can produce extremely
high and seemingly statistically signiﬁcant canonical correlations even
when there is no relationship between data modalities and a clustering
procedure that will always produce some clusters regardless of the
input data.
5. Conclusion
To the best of our knowledge, this is the ﬁrst attempt to replicate the
methodological pipeline used in Drysdale et al. and to extend it to a
diﬀerent clinical sample of patients with depression and anxiety dis-
orders. Extending the original methods with additional more rigorous
statistical procedures, we did not ﬁnd stable or statistically signiﬁcant
biotypes of depression and anxiety in an independent sample from a
diﬀerent clinical population. Furthermore, we have argued that the
evidence for the existence of 4 distinct biotypes presented in the ori-
ginal study, namely stability of the clustering solution and magnitude of
the clustering index, is not suﬃcient to conclude (or disprove) the ex-
istence of distinct biotypes and the results should therefore, be inter-
preted with care. However, even without partitioning patients into
biotypes, the existence of continuous biological axes related to symp-
toms of depression might be even more useful for our understanding of
biological mechanisms of depression and clinical practice. This con-
clusion is not based on the direct comparison of results between the
present study and Drysdale et al. (which would not be possible due to
sample diﬀerences), but it is based on our evaluation of statistical
properties of the methods used in the original study.
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